![]() |
||||||
|
||||||
Risk-taking: behind the warrior gene
story
Tony Merriman, Vicky Cameron
In the second week of August 2006, the media were gripped
with the announcement that Māori men were genetically predisposed to
“violence, criminal acts, and risky behaviour.” (Christchurch
Press, 9 August 2006). The basis for this release was the report of a study
that purported to show that a genetic variant of the monoamine oxidase
(MAO)-A gene, dubbed the “warrior gene” by the media, had
previously been “strongly associated with risk taking and aggressive
behaviour” and was “strikingly over-represented” in Māori
men.1
Because these findings were
released at an international conference by a government-funded researcher, there
has generally been an assumption that the link between the MAO-A
variant and aggression in Māori is based on robust scientific evidence.
Here we place the scientific evidence under closer scrutiny.
The regulatory region of the
human MAO-A gene has a genetic variation consisting of a small stretch
of DNA repeated a variable number of times.2
The 3-repeat form of this ‘variable number of tandem repeats (VTNR)’
polymorphism (present on 33% of Caucasian chromosomes) exhibits up to 10-fold
less activity than the 4-repeat form (present in 65% of Caucasian), and has been
commonly termed the ‘low-activity’
variant.2
The MAO-A gene controls the
production of the MAO-A enzyme, which is involved in the breakdown of several
neurotransmitters in the brain, such as dopamine and serotonin. It is believed
that this enzyme is important in preventing the build-up of an excess of these
transmitters. In MAO-A deficient mice that lack the enzyme altogether,
increased levels of neurotransmitters were documented and the mice were observed
to exhibit aggressive behaviour.3
In a Dutch family, a
dysfunctional MAO-A gene has been linked to antisocial behaviour and
increased aggression amongst humans.4 Based on
this observation, the MAO-A VNTR has been tested for association with
antisocial behaviour in population-based male cohorts. The three largest studies
(all in groups of Caucasian ethnicity) published remarkably consistent findings;
no main effect was found for the relationship between the MAO-A VNTR
genotype and antisocial behaviour, but the high-activity form was
associated with buffering males who were abused and neglected in childhood from
increased risk of anti-social behaviour later in
life.5–7 That is, there was evidence for
a gene-environment interaction where the effect of the MAO-A
low-activity variant was dependent on the environment—analysed in
isolation the gene variant could predict nothing about aggression in male
carriers.
This effect was, however, not
evident in a cohort of American non-whites.7 A
possible biological explanation of the genetic findings is that the
higher-activity variant produces more MAO-A enzyme and is better able to mop up
excess neurotransmitters, such as dopamine and serotonin, in the brain.
It is clear from the genetic data that MAO-A itself
is not associated with aggression (contrary to the interpretation by
Lea and colleagues of “strong” association with aggressive
behaviour1). More generally, it is important to
emphasise that the strong, clear, and direct causal relationship implied by the
phrase of “a gene for...” does not exist for psychiatric
disorders.8
The MAO-A gene was termed the “warrior gene” on
the basis of experiments in Rhesus macaque
monkeys.9 These primates have a comparable VNTR
upstream of the MAO-A gene with the 5- and 6-repeat forms having 1.3-fold
greater activity than the longer 7-repeat
form.9 However, in contrast to the human gene,
in the Rhesus macaque, fewer repeats means more MAO-A enzyme is produced.
When tested for association with aggressive behaviour in 45
male macaque monkeys there was no main effect of genotype on aggression. There
was, however, evidence for a gene-environment interaction; in peer-reared
monkeys, the higher-activity allele was associated with aggression, whereas in
mother-reared monkeys the lower-activity variant was associated with
aggression.9
This gene-environment interaction superficially conflicts
with the human data, although there are numerous reasons (including species
difference) that could account for this apparent
conflict.9 Nevertheless, on the basis of one
un-replicated experiment on only 45 animals, the MAO-A gene was
(dubiously) termed the “warrior gene” at the 2004 Annual Meeting of
the American Association of Physical Anthropologists by a scientific
journalist.10
As far as we are aware, the term “warrior gene”
has not been applied to humans in previous studies of MAO-A and
aggression. Dr Lea and colleagues reported that the frequency of the 3-repeat
short form of the MAO-A VNTR was just over 60% in a very small sample
of 17 Māori males.1 Based on these data
they concluded that “positive selection of MAO-A associated with
risk taking and aggressive behaviour has occurred during the Polynesian
migrations” and termed the low-activity variant the “warrior
allele”. The MAO-A gene was then linked to antisocial behaviour
in contemporary Māori males in the publicity surrounding the conference
presentation.
We believe that this
conclusion is based on science with insufficient investigative rigor, both in
interpreting and applying the relevant literature, and in generating new data.
Central to the argument of Dr
Lea and colleagues1 is the assumption that the
low-activity MAO-A allele is associated with aggression in Māori
males. This assumption cannot be made without the appropriate genetic
epidemiological experiments being done to test for an association between
MAO-A and aggression. However no such study has ever been reported.
The lack of evidence for involvement of this variant with
violence and antisocial behaviour in American
non-whites7 demonstrates that extreme caution
is needed when translating MAO-A genetic findings between racial
groups. A central tenet of complex phenotype genetics is that genetic
associations are likely to vary between racial groups.
There is no direct evidence to support the claim that the
MAO-A gene confers “warrior” qualities on Māori males,
either modern or ancestral. Furthermore, the assumption that a genetic
association in Caucasian applies in Māori; the use of the “warrior
gene” label in the context of human MAO-A aggression studies;
generalising from a sample of 17 individuals not representative of the general
Māori population; and the lack of scientific investigative journalism have
combined to do science and Māori a disservice.
Conflict of interest statement: There
are no conflicts of interest.
Author information: Tony Merriman, Senior
Research Fellow, Department of Biochemistry, Otago School of Medical Sciences,
University of Otago, Dunedin; Vicky Cameron, Research Associate Professor,
Christchurch Cardioendocrine Research Group, Christchurch School of Medicine and
Health Sciences (University of Otago), Christchurch
Correspondence:
Dr Tony Merriman, Department of Biochemistry, Otago School of Medical
Sciences, University of Otago, PO Box 56, Dunedin. Fax: (03) 479 7866; email: tony.merriman@stonebow.otago.ac.nz
References:
|
||||||
| Current
issue | Search journal |
Archived issues | Classifieds
| Hotline (free ads) Subscribe | Contribute | Advertise | Contact Us | Copyright | Other Journals |